Company intelligence / Profile preview

Cordance Medical

Mountain View, California, United States

Ownership: Private
Development stage: Other

Overview

Cordance Medical is developing the NeuroAccess focused ultrasound device to safely and temporarily open the blood–brain barrier for liquid biopsy and drug delivery in brain cancer and other brain diseases; as of late 2025 the company has preclinical data, FDA Breakthrough Device Designation in neuro-oncology, NIH/NCI funding, and is preparing/initiating its first-in-human clinical trial, but no clinical efficacy results are yet reported publicly.[1][3][4][5]

Therapeutic areas: OncologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of Health (National Cancer Institute grant-supported trial)[5]

Beyond the preview

Go deeper on Cordance Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cordance Medical.

Explore the full profile